Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells

Molecular and Cellular Biology

Volumn 22, Issue 3, 2002, Pages 724-736

  Choi, Chulhee ^a   Kutsch, Olaf ^a   Park, Jinseu ^a   Zhou, Tong ^a   Seol, Dai Wu ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; CASPASE; CASPASE 1 INHIBITOR; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE INHIBITOR; CHEMOKINE; DR5 PROTEIN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; RECEPTOR PROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TRAIL PROTEIN RECEPTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; GLIOMA CELL; HUMAN; HUMAN CELL; INFLAMMATION; LIGAND BINDING; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0036143575     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.3.724-736.2002     Document Type: Article

References (54)

1. The CXC chemokine receptor 2. CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
2. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
3. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils
4. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx
5. Proteases for cell suicide: Functions and regulation of caspases
6. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway
7. Fas-induced expression of chemokines in human glioma cells: Involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase
8. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
9. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
10. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis
11. Interleukin-18 and interleukin-1 beta: Two cytokine substrates for ICE (caspase-1)
12. Expression of TRAIL and its receptors in human brain tumors
13. The TRAIL to selective tumor death
14. Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents
15. Apoptosis. Death deceiver
16. How TRAIL kills cancer cells, but not normal cells
17. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways
18. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
19. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer
20. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
21. Interleukin-8 as a macrophage-derived mediator of angiogenesis
22. Cancer surveillance series [corrected]: Brain and other central nervous system cancers: Recent trends in incidence and mortality
23. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
24. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of 1κB kinase and c-Jun N-terminal kinase
25. The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice
26. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8
27. 2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways
28. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
29. Fas and Fas ligand: A death factor and its receptor
30. APO2L/TRAIL expression in human brain tumors
31. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-beta
32. Cytokine regulation of CC and CXC chemokine expression by human astrocytes
33. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
34. The receptor for the cytotoxic ligand TRAIL
35. APO2 ligand: A novel lethal weapon against malignant glioma?
36. Human astrocytic brain tumors express APO2L/TRAIL
37. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity
38. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: A key role in brain inflammation?
39. Differential expression and responsiveness of chemokine receptors (CXCR1-R3) by human microvascular endothelial cells and umbilical vein endothelial cells
40. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB
41. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis
42. IL-8 expression in malignant melanoma: Implications in growth and metastasis
43. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
44. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
45. The role of CXC chemokines as regulators of angiogenesis
46. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
47. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
48. Cleavage of mitogen-activated protein kinases in human neutrophils undergoing apoptosis: Role in decreased responsiveness to inflammatory cytokines
49. The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation
50. Caspases: Enemies within
51. Tumor necrosis factor receptor and Fas signaling mechanisms
52. Caspase-dependent cleavage of signaling proteins during apoptosis, A turn-off mechanism for anti-apoptotic signals
53. Induction of apoptosis in glioma cell lines by TRAIL/Apo-2L
54. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells